|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2001
A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia
Respiratory Medicine, Nottingham City Hospital, Nottingham, UK
CORRESPONDENCE: J.T. Macfarlane, Respiratory Medicine, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK. Fax: 44 1159627723
Keywords: aetiology, cohort study, community acquired pneumonia, nursing home acquired pneumonia
Received: January 12, 2001
Accepted March 20, 2001
This study was supported by a research grant from Hoechst Marion Roussel.
Nursing home acquired pneumonia (NHAP) is thought to be clinically distinct from community acquired pneumonia (CAP). This observation, based on studies conducted mainly in North America, may not be relevant in countries with a different healthcare system.
The authors describe an 18-month prospective cohort study of 437 patients admitted to hospital with CAP, 40 (9%) of whom came from nursing homes. Detailed microbiological tests were performed in a subset of patients over 12 months.
Patients with NHAP were less likely to have a productive cough (odds ratio (OR) 0.4, p=0.02) or pleuritic pain (OR 0.1, p=0.03), but they were more likely to be confused (OR 2.6, p<0.001). They had poorer functional status (p<0.001) and more severe disease (p=0.03). Mortality was higher compared to CAP (53% versus 13%), but this was mainly explained by prior functional status (OR 0.5, after adjustment for functional status). Pathogens were identified in 68% of 22 NHAP and 80% of 44 matched CAP patients. Streptococcus pneumoniae was the most common (55% NHAP, 43% CAP). Atypical pathogens, enteric Gram negative bacilli and Staphylococcus aureus were uncommon.
In conclusion, differences in functional status accounted for the increased mortality in nursing home acquired pneumonia compared to community acquired pneumonia. The pathogens implicated were similar. No grounds for a difference in choice of empirical antibiotics were apparent.
This article has been cited by other articles:
|
|
 |
|
  T. Maruyama, O. Taguchi, M. S Niederman, J. Morser, H. Kobayashi, T. Kobayashi, C. D'Alessandro-Gabazza, S. Nakayama, K. Nishikubo, T. Noguchi, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial BMJ, March 8, 2010; 340(mar08_1): c1004 - c1004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Defres, C. Marwick, and D. Nathwani MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia Eur. Respir. J., December 1, 2009; 34(6): 1470 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W S Lim, S V Baudouin, R C George, A T Hill, C Jamieson, I Le Jeune, J T Macfarlane, R C Read, H J Roberts, M L Levy, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009 Thorax, October 1, 2009; 64(Suppl_3): iii1 - iii55. [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Kollef Health-Care-Associated Pneumonia: Not Just a US Phenomenon Chest, March 1, 2009; 135(3): 594 - 596. [Full Text] [PDF]
|
|
|
|
|
|
Y. Shindo, S. Sato, E. Maruyama, T. Ohashi, M. Ogawa, N. Hashimoto, K. Imaizumi, T. Sato, and Y. Hasegawa Health-Care-Associated Pneumonia Among Hospitalized Patients in a Japanese Community Hospital Chest, March 1, 2009; 135(3): 633 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Grossman Hospital-Acquired and Ventilator-Associated Pneumonia ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 391 - 400. [Full Text] [PDF]
|
|
|
|
|
|
H. Kothe, T. Bauer, R. Marre, N. Suttorp, T. Welte, K. Dalhoff, and the Competence Network for Community-Acquired Pneu Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment Eur. Respir. J., July 1, 2008; 32(1): 139 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yan Man, N. Lee, M. Ip, G. E Antonio, S. S L Chau, P. Mak, C. A Graham, M. Zhang, G. Lui, P. K S Chan, et al. Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong Thorax, April 1, 2007; 62(4): 348 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. de Roux, S. Ewig, E. Garcia, M. A. Marcos, J. Mensa, H. Lode, and A. Torres Mixed community-acquired pneumonia in hospitalised patients. Eur. Respir. J., April 1, 2006; 27(4): 795 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 388 - 416. [Full Text] [PDF]
|
|
|
|
|
|
A. Ortqvist Treatment of community-acquired lower respiratory tract infections in adults Eur. Respir. J., July 1, 2002; 20(36_suppl): 40S - 53s. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |